ABSTRACT
INTRODUCTION
S.aureus is an opportunistic commensal, emerging as an important human pathogen. Multi drug resistance of invasive S.aureus can cause life threatening infections such as endocarditis, osteomyelitis, surgical site infections, bloodstream infections, pulmonary abscesses and sepsis. S.aureus is also capable of producing septic shock. Unlike the structural components noted earlier, these superantigens can produce a sepsis-like syndrome by initiating a "cytokine storm." Some strains also produce epidermolysins or exfoliative toxins capable of causing scalded skin syndrome or bullous impetigo [1] . Methicillin was first introduced in 1959-1960 for the treatment of Staphylococcal infections, and, within a year, methicillin-resistant isolates were reported [2] . Recently MRSA has emerged as the major etiological agent in hospital and community acquired infections [3] . Antibiotic resistance in human pathogens has dominated worldwide [4] . Many MRSA outbreaks have been reported [3] . MRSA infections kill approximately 19,000 hospitalized American patients annually; this is similar to the number of deaths due to AIDS, tuberculosis, and viral hepatitis combined (5). Later on, vancomycin was used as the drug of choice for treating MRSA infections. Vancomycin was discovered in 1950, a glycopeptide was isolated from Streptomyces orientalis. There has been increasing trend in the prevalence of vancomycin resistance among S. aureus. The increase in vancomycin resistance among MRSA and excessive use of antimicrobial agents has worsened the sensitivity, calls for further epidemiological studies. Alarmingly, the origin and spread of VRSA is being extensively reported across the globe including from the Indian subcontinent. First clinical isolate of vancomycin resistant S. aureus (VRSA) was reported from United States in 2002 [6] . More recently vancomycin resistant Staphylococcal stains from Brazil [7] and Jordan [8] has been reported. 
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Over the years, modulation of bacteria in emerging as a drug resistance has become one of the concerned topic in the current research. The present study was carried out to assess the trends in the prevalence and potential risk of MRSA and VRSA in Gulbarga region.
MATERIALS AND METHODS
Clinical samples such as pus, blood and urine were collected from diagnostic and primary health care centers in Kalaburagi region via, transport media and enriched in brain heart infusion broth overnight. Enriched cultures were inoculated onto the mannitol salt agar and baird parker agar plates and processed for coagulase test. Further S.aureus isolates were confirmed by standard biochemical tests (9) . Antimicrobial susceptibility test: Following are the antibiotics (Himedia, India) used in the present study -penicillin-P(10 units), oxacillin-OX (1mcg), cefoxitin-
cloramphenicol-C (30mcg), rifampicin-RIF (5mcg), erythromycin-E (15mcg), linezolid-LZ (30mcg). Antibiotic susceptibility test was carried out by Kirby-Bauer disc diffusion method according to CLSI guidelines 2014(10).
RESULTS
A total of 120 clinical samples of pus, blood and urine were screened and 51% of samples were confirmed for S.aureus. Incidence of S.aureus is more in pus with 60.34% followed by urine 45.45% and Blood 42.5%. Antibiotic resistance patterns of S.aureus showed highest resistance for penicillin (98%) and least (4.8%) for chloramphenicol. All the isolates were susceptible to imipenem. Varying range of resistances were recorded for other antibiotics from 7.7% against tetracycline to 76.9% for amoxicillin (Fig.1) . About 38.7% of the isolates have been confirmed as MRSA and incidence of VRSA was 4.8% (Fig.2) . Similarly, the incidence of MRSA and VRSA was more in urine samples (Table-1) . . In India MRSA prevalence was studied in South Gujarat, Tamil Nadu, Chandigarh, Assam, Varanasi, Nagpur, Vellore, Indore and was found to be 39.50%, 31.10%, 24%, 52.90%, 38.44%, 19%, 24%,80.89% respectively (14) . In the present study prevalence of antibiotic resistance patterns were determined among S. aureus isolates against 21 antibiotics [ Fig.1 ]. Almost total (98%) resistance was observed against penicillin, and alarming very high resistance was observed other beta lactum antibiotics like amoxycillin and cefotaxime, 76.9 and 73.1%. The incidence of MRSA was 38.7% which almost comparable to the incidence of MRSA in other parts of India (15) . Though the incidence of VRSA is very low (4.8%) it is alarming that both MRSA and VRSA combined will pose a greater threat for the treatment of staphylococcal infections. Most MRSA isolates are resistant to multiple antibiotics and more than 50% are resistant to rifampicin, compared to methicillin-susceptible S. [17] . The percentage of resistance was found higher to most of the antibiotics in tertiary care centers compared to out-patients departments in hospitals and diagnostic centers. Previous study from this lab (18) also indicated that all MRSA reported were sensitive to vancomycin. However, a recent study (19) indicate a rise in the prevalence of VRSA among MRSA which is cause for utmost concern.
CONCLUSION
Variation in resistance patterns has been observed, this could be due to nature of samples and conditions of the patients while collecting the samples. While reporting we have to specify criteria of random sampling or specific sampling to determine accurate prevalence of the specific region. Quinapristin/ dalfopristin, quinupristin and newer generation fluoroquinolones, fusfomycin, fusicidic acid remained as a choice of drug for the treatment of MRSA infections. Careful monitoring of emergence of drug resistance pathogens is required to control the spread of infections.
